Largest brain sits at the center of this dementia and brain health question.

The Preventing Alzheimer’s with Cognitive Training (PACT) study, the largest brain training trial of its kind, has secured $2.8 million in federal funding from the National Institutes of Health to investigate whether computerized cognitive exercises can reduce dementia risk in older adults. This groundbreaking study, begun in 2026 at the University of South Florida, is enrolling 7,600 older adults across 10 research sites in the southeastern United States and represents a major institutional commitment to testing whether accessible, home-based brain training can meaningfully delay or prevent cognitive decline. The investment reflects growing evidence that even modest mental exercise may protect against dementia for decades—but also acknowledges that much remains unknown about which types of training work best, for whom, and whether improvements in lab settings translate to real-world protection. The PACT trial is led by Jennifer O’Brien, Associate Professor of Psychology at USF St.

Petersburg, and marks a departure from smaller, laboratory-based studies. By enrolling participants across diverse demographic groups at multiple sites including Duke University, Clemson University, and the University of Florida, the researchers are testing whether cognitive training benefits actually hold up in a large, representative population. Over three years, participants will complete approximately 45 hours of computerized brain training exercises from home, with initial training delivered during two in-person visits where researchers teach the cognitive activities directly. This article explores what the PACT study aims to achieve, how it works, what existing research suggests about brain training’s promise, and what barriers or limitations researchers and participants will need to navigate.

What Makes the PACT Study the Largest Brain Training Trial to Date?
How Does Brain Training Work in the PACT Study, and What Are Its Limitations?
Who Can Participate, and What Does the Research Timeline Look Like?
What Do Existing Studies Suggest About Brain Training and Dementia Prevention?
What Barriers Might Affect Who Benefits From PACT, and What Should Potential Participants Know?
How Does the PACT Study Fit Into Broader Dementia Prevention Efforts?
What Will Determine Whether Brain Training Becomes Mainstream Dementia Prevention?
Conclusion

What Makes the PACT Study the Largest Brain Training Trial to Date?

The PACT study’s size and scope represent a significant escalation in dementia prevention research. With 7,600 enrolled older adults across 10 geographically dispersed sites, the trial is designed to generate robust evidence that can apply beyond a narrow slice of the population. Most prior brain training studies enrolled hundreds or at most a few thousand participants, often from a single university or region, limiting how broadly their results could be generalized. The PACT researchers deliberately recruited across key demographic groups—meaning they aren’t just testing affluent, highly educated people in academic medical centers, but including participants with varying education levels, socioeconomic backgrounds, and access to technology.

This diversity matters because dementia doesn’t affect populations equally; African Americans and Hispanics, for example, face higher incidence rates, yet are often underrepresented in clinical research. The $2.8 million award represents recent federal funding, but the PACT study has already secured over $50 million in cumulative federal grant funding from the NIH, demonstrating sustained institutional confidence in the research question. That level of investment allows for rigorous infrastructure: certified research coordinators at each site, standardized training protocols, data quality monitoring, and long-term follow-up to track whether participants who complete brain training actually develop dementia at lower rates than a comparison group. Without this scale and funding, researchers would lack the statistical power to detect modest but clinically important differences in dementia incidence—especially when waiting years or decades for outcomes to emerge.

What Makes the PACT Study the Largest Brain Training Trial to Date?

How Does Brain Training Work in the PACT Study, and What Are Its Limitations?

Participants in PACT will engage in computerized cognitive exercises focused on speed of processing—that is, how quickly the brain can perceive, interpret, and act on information. This choice reflects prior research suggesting that cognitive speed training shows the most promising results for dementia prevention compared to other types of mental exercise like memory training or reasoning practice. The exercises are designed to be challenging but achievable, progressively increasing in difficulty to keep the brain engaged without causing frustration. Participants log in from home and complete these exercises over a three-year period, totaling about 45 hours—roughly 15 hours per year or less than one hour per month on average.

However, a critical limitation of the PACT study is that it cannot yet answer whether improvements in processing speed on a computer screen actually translate to protection against real-world cognitive decline and dementia. Related research from Johns Hopkins Medicine has shown that cognitive speed training is linked to lower dementia incidence up to 20 years post-intervention, suggesting the connection is plausible. But PACT participants are still early in their three-year training period, so we will not know for years whether this large group experiences the same benefits. Additionally, the study may underrepresent people with low digital literacy or limited internet access—exactly some of the populations most vulnerable to dementia. If only tech-savvy older adults complete the training consistently, the real-world benefit could be smaller than what the trial measures.

Who Can Participate, and What Does the Research Timeline Look Like?

The PACT study is actively enrolling older adults at 10 sites across the southeastern U.S. Eligibility typically requires being 60 years or older, cognitively normal at baseline (no diagnosis of dementia or mild cognitive impairment), and able to commit to three years of home-based cognitive training. The two in-person visits allow researchers to verify participants’ baseline cognitive status and ensure they understand how to use the computerized exercises correctly. This human element is often overlooked in discussions of “computerized” brain training, but the in-person instruction appears to be important for compliance and proper engagement with the exercises.

The research timeline extends well beyond the three-year training period. Participants will be followed for years afterward to determine whether those who completed brain training have lower rates of cognitive decline or dementia diagnosis. This long follow-up window—informed by prior research showing dementia risk reduction up to 20 years after training—is why such large federal investments are necessary. A dementia prevention study cannot be completed in a year or two; it requires sustained funding, stable research teams, and databases capable of tracking thousands of people across multiple institutions over a decade or more.

Who Can Participate, and What Does the Research Timeline Look Like?

What Do Existing Studies Suggest About Brain Training and Dementia Prevention?

Recent research has moved past the question of whether brain training is completely useless to examining which specific types, intensities, and populations benefit most. A study highlighted by NPR found that even modest mental exercise—described as just five weeks of brain training—can reduce risk of dementia for decades afterward in some people. The Johns Hopkins research on cognitive speed training was more specific: participants who engaged in speed-of-processing training showed a lower dementia incidence compared to a control group, with benefits observable up to 20 years later. This persistence over decades is striking and suggests that cognitive training may have a lasting protective effect rather than just temporary improvements in lab performance.

The comparison between different brain training approaches is important. Speed-of-processing training appears to show more promise than memory training or reasoning exercises, which is why PACT focuses on processing speed. However, no study to date has proven that brain training is equivalent to, say, regular physical exercise (which has stronger dementia prevention evidence) or cognitive engagement through novel, socially interactive activities like learning a new language or musical instrument. PACT is not claiming brain training is a complete replacement for cardiovascular exercise, cognitive stimulation through hobbies, or strong social connections—all of which independently support brain health. Instead, the study will help clarify whether computerized speed training offers an additional layer of protection for those who complete it.

What Barriers Might Affect Who Benefits From PACT, and What Should Potential Participants Know?

One of the most overlooked challenges in dementia prevention research is adherence. Completing 45 hours of computerized exercises over three years requires sustained motivation, reliable internet access, and comfort with technology. Older adults with limited digital skills, vision problems, or hearing loss may struggle with the exercises despite their cognitive health. Additionally, socioeconomic factors matter: someone juggling caregiving responsibilities, multiple jobs, or transportation challenges may have less bandwidth for home-based cognitive training, even if they understand its potential value.

The PACT researchers have built in support—research coordinators can troubleshoot technical problems and provide encouragement—but not every barrier can be overcome through study design alone. Another limitation is that PACT cannot test whether brain training works equally well across different levels of genetic dementia risk. Apolipoprotein E (APOE) genotype is a strong genetic risk factor for Alzheimer’s disease, and some evidence suggests that cognitive training might be more protective for people with certain genetic profiles. However, PACT may not have sufficient power to detect these interactions, meaning that if brain training works best for a specific genetic subgroup, that finding could be missed in the overall results. Potential participants should also know that PACT will likely take until the early 2030s or later to produce dementia outcome data, so this is not a study that will quickly validate or refute brain training’s promise.

What Barriers Might Affect Who Benefits From PACT, and What Should Potential Participants Know?

How Does the PACT Study Fit Into Broader Dementia Prevention Efforts?

The PACT trial is one piece of a larger dementia prevention landscape that includes pharmacological trials (like the anti-amyloid antibody trials for early-stage disease), lifestyle interventions (diet, exercise, cognitive stimulation combined), and epidemiological studies tracking which factors protect or harm the brain over time. Brain training occupies a unique niche: it is scalable (millions of people can use computerized exercises), relatively low-cost compared to medications or intensive lifestyle programs, and accessible to people with mobility limitations or transportation challenges. If PACT demonstrates that cognitive speed training reduces dementia incidence, it could become a public health tool deployed through libraries, senior centers, or healthcare systems at scale.

The federal investment in PACT also signals that the NIH views dementia prevention as urgent and worthy of sustained commitment. The $2.8 million award is recent (from 2026), but it is part of a cumulative $50 million in NIH funding for this study. This consistency of support contrasts with many smaller research questions that receive one-time funding and are then abandoned if results don’t emerge quickly. Dementia researchers have advocated for this kind of long-term commitment, arguing that prevention studies cannot succeed without stable funding over decades.

What Will Determine Whether Brain Training Becomes Mainstream Dementia Prevention?

The PACT study will produce its first major results in the early 2030s when participants complete three years of training and preliminary cognitive outcomes become available. Dementia diagnosis data will come later, as the longer follow-up unfolds. If PACT shows that cognitive speed training substantially reduces dementia risk across diverse populations, the next steps would include examining cost-effectiveness (is brain training worth deploying at scale?), determining optimal training dosage (is 45 hours enough, or do people need more?), and identifying subgroups who benefit most. If results are equivocal or modest, researchers and funders will need to decide whether to pursue different training approaches, longer training periods, or combinations of brain training with other dementia prevention strategies.

One question looming over dementia prevention research is whether behavioral and cognitive interventions can ever compete with emerging pharmacological treatments. Anti-amyloid antibodies like aducanumab and lecanemab are showing promise in slowing cognitive decline in early Alzheimer’s disease, though they come with risks, cost thousands of dollars per year, and require regular infusions or injections. Brain training, by contrast, is low-risk and could be much cheaper—but only if it is proven effective and can be delivered at scale. PACT is, in effect, testing whether the brain’s own plasticity and adaptive capacity can be harnessed to prevent dementia, or whether pharmaceutical interventions will ultimately dominate dementia prevention in the coming decades.

Conclusion

The PACT study represents the most ambitious test to date of whether computerized brain training can reduce dementia incidence in a large, diverse population of older adults. With 7,600 participants across 10 sites, three years of home-based cognitive training, and federal funding exceeding $50 million cumulatively, the researchers have built the infrastructure necessary to generate credible evidence about whether speed-of-processing training translates into real dementia prevention. The $2.8 million recent federal award sustains this momentum and reflects confidence that the research question matters for public health.

Potential participants and people interested in dementia prevention should view PACT as one promising avenue among many—not a guaranteed solution, but a carefully designed study that could shift how we approach cognitive aging. In the meantime, the existing evidence for cognitive speed training’s protective effects, combined with decades of research on physical exercise, social engagement, and cognitive stimulation, suggests that multiple strategies working together—not brain training alone—offer the best hope for preserving cognitive function into advanced age. As PACT unfolds over the coming years, it will clarify whether computerized brain training deserves a central place in dementia prevention efforts or whether it remains a useful but modest tool in a larger prevention toolkit.